|Articles|November 6, 2015

Patient Engagement & Rare Diseases Podcast

Author(s)DIA

Patient Engagement & Rare Diseases Podcast

Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders speaks with Global Forum Deputy Editor Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases on DIA’s podcast channel, Driving Ideas to Action.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Patient Engagement & Rare Diseases Podcast

Related Content

U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report

Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI

Ovarian Cancer: Closing Gaps and Advancing Care with RWD

Pharmaceutical Executive Daily: Alnylam Pharmaceuticals and Inceptive Nucleics Announce 3 Year Strategic Collaboration

Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive

Trending on PharmExec

Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive

U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report

Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI

Navigating PBM Pitfalls: Protecting Revenue in a Complex Rebate Landscape

Pharmaceutical Executive Daily: New FDA Draft Guidance Targets Gene Therapy Submission Burden